173 related articles for article (PubMed ID: 31531779)
1. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; D'Alessandro P; Arduino B; de Placido G; Mascolo M; Insabato L; Zullo F
Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
[TBL] [Abstract][Full Text] [Related]
2. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.
Raffone A; Travaglino A; Saccone G; Cieri M; Mascolo M; Mollo A; Insabato L; Zullo F
APMIS; 2019 Sep; 127(9):597-606. PubMed ID: 31237034
[TBL] [Abstract][Full Text] [Related]
4. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
5. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
[TBL] [Abstract][Full Text] [Related]
6. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus Is Associated with Occult Cancer in Endometrial Hyperplasia.
Raffone A; Travaglino A; Saccone G; D'Alessandro P; Arduino B; Mascolo M; De Placido G; Insabato L; Zullo F
Pathol Oncol Res; 2020 Jul; 26(3):1377-1384. PubMed ID: 31203571
[TBL] [Abstract][Full Text] [Related]
9. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
[TBL] [Abstract][Full Text] [Related]
10. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
11. Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
[TBL] [Abstract][Full Text] [Related]
12. Endometrial hyperplasia and the risk of progression to carcinoma.
Lacey JV; Chia VM
Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
[TBL] [Abstract][Full Text] [Related]
13. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
[TBL] [Abstract][Full Text] [Related]
15. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
[TBL] [Abstract][Full Text] [Related]
16. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
17. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.
Salman MC; Usubutun A; Boynukalin K; Yuce K
J Gynecol Oncol; 2010 Jun; 21(2):97-101. PubMed ID: 20613899
[TBL] [Abstract][Full Text] [Related]
18. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
19. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
[TBL] [Abstract][Full Text] [Related]
20. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
Kender Erturk N; Basaran D; Salman C
J Obstet Gynaecol; 2022 May; 42(4):692-695. PubMed ID: 34415826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
